Xiaochen Li
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Inflammasome and immune disorders 8
- Natural product bioactivities and synthesis 3
- CRISPR and Genetic Engineering 3
- Rheumatology 14
- Osteoarthritis Treatment and Mechanisms 9
- Spondyloarthritis Studies and Treatments 3
- Co-authors
- Runlin Xing (13 shared papers)Li Zhang (12 shared papers)Zhengquan Huang (9 shared papers)Peimin Wang (6 shared papers)Peimin Wang (10 shared papers)Liang Ding (7 shared papers)Jun J. Mao (5 shared papers)Bo Xu (6 shared papers)
- Journals
- Frontiers in Pharmacology (6 papers)Journal of Clinical Oncology (3 papers)Journal of Advanced Research (2 papers)Biotechnology Letters (2 papers)BioMed Research International (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaochen Li
45 papers receiving 954 citations
Peers
Comparison fields: 5 of 105
- Rheumatology 312
- Nephrology 85
- Molecular Biology 511
- Sensory Systems 33
- Pharmacology 114
Countries citing papers authored by Xiaochen Li
This map shows the geographic impact of Xiaochen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaochen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaochen Li more than expected).
Fields of papers citing papers by Xiaochen Li
This network shows the impact of papers produced by Xiaochen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaochen Li. The network helps show where Xiaochen Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaochen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 100 | |
| 2 | 2019 | 78 | |
| 3 | 2020 | 55 | |
| 4 | 2015 | 55 | |
| 5 | 2021 | 53 | |
| 6 | 2019 | 53 | |
| 7 | 2021 | 53 | |
| 8 | 2015 | 49 | |
| 9 | 2017 | 48 | |
| 10 | 2020 | 46 | |
| 11 | 2020 | 38 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 31 | |
| 14 | 2021 | 31 | |
| 15 | 2020 | 31 | |
| 16 | 2021 | 28 | |
| 17 | 2023 | 25 | |
| 18 | 2021 | 18 | |
| 19 | 2023 | 14 | |
| 20 | 2021 | 14 |
About Xiaochen Li
Xiaochen Li is a scholar working on Molecular Biology, Rheumatology, Nephrology, Pharmacology and Physiology, having authored 49 papers that have together received 970 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (9 papers), Inflammasome and immune disorders (8 papers), Gout, Hyperuricemia, Uric Acid (6 papers), Cancer-related molecular mechanisms research (4 papers), Ion Channels and Receptors (4 papers), Natural product bioactivities and synthesis (3 papers), CRISPR and Genetic Engineering (3 papers) and Spondyloarthritis Studies and Treatments (3 papers). The work is most often cited by research in Rheumatology (312 citations), Nephrology (85 citations), Molecular Biology (511 citations), Sensory Systems (33 citations) and Pharmacology (114 citations). Xiaochen Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Runlin Xing, Li Zhang, Zhengquan Huang, Peimin Wang, Peimin Wang, Liang Ding, Jun J. Mao, Bo Xu, Songjiang Yin and Zhang Li. Their work appears in journals such as Frontiers in Pharmacology, Journal of Clinical Oncology, Journal of Advanced Research, Biotechnology Letters and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.